The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Interactions · continued

Common supplements people ask about, assessed one at a time — a second dataset posts 61–90

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

F
FFaulknerTL3Regular3 Mar 2026#61

Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.

Adding this to the thread rather than to the wiki, because I am not confident enough for the wiki.

2 likes 5mo
HR
h.ramosTL24 Mar 2026#62

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

8 likes 5mo
T
TamburelloTL2Member6 Mar 2026#63
t.wojcik, post #17: Answering the question post #14 raises rather than the one it answers. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion. That has held every time I have looked, which is not the same as… Go to post

Fine by me. I had wanted a stronger conclusion and there is not one available.

26 likes in reply to #17 5mo
VO
v.okonkwoTL28 Mar 2026#64

On post #60 — agreed on the reasoning, with one qualification.

Common supplements is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.

0 likes 5mo
I
IMainwaringTL3Regular10 Mar 2026#65

Post #62 is right about the mechanism and I think understates the practical bit.

Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance would suggest.

The uncertainty is in the assumption, not in the calculation.

0 likes 5mo
LL
l.lundgrenTL211 Mar 2026 · edited#66
PSundberg, post #55: Answering the question post #53 raises rather than the one it answers. Careful with the language on Common supplements. "Not detected" and "not present" are different findings and the first is a statement about the method. Go to post

One more thing on Common supplements that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.

4 likes in reply to #55 5mo
N
NardoneTL2Member13 Mar 2026#67
c.ostergaard, post #12: SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is not supported.

Posted with less confidence than the sentence structure implies.

19 likes in reply to #12 5mo
LV
l.vermeulenTL215 Mar 2026#68

Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as one.

0 likes 4mo
AK
a.kwiatkowskiTL2Member16 Mar 2026#69

Building on post #66 rather than restating it.

Marking my uncertainty on Common supplements explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises past the case in the first post.

7 likes 4mo
MA
m.amankwahTL218 Mar 2026#70

Post #68 put the caveat in the right place and I want to underline it.

Agreed on Common supplements, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the starting assumption is the part nobody states.

18 likes 4mo
RB
r.bakkenTL220 Mar 2026#71

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

Correct me on the arithmetic if it is wrong; I would rather know.

0 likes 4mo
CW
c.wijnbergTL2Member21 Mar 2026#72

An observation about Common supplements that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.

0 likes 4mo
KK
k.kuuselaTL223 Mar 2026#73
cannula_trace, post #3: Common supplements sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly. Go to post

Worth separating two things that post #71 runs together.

The claim about Common supplements upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".

12 likes in reply to #3 4mo
NR
n.rowntreeTL325 Mar 2026#74
NA
n.achebeTL226 Mar 2026#75

I would be cautious about generalising from the Common supplements example above. It is a good example. It is one example.

1 like 4mo
FE
footnote_entryTL3Regular28 Mar 2026#76

Narrowing post #75, because the general version has more than one answer.

Two sentences on Common supplements and then I will stop, because the rest is speculation and the thread is better without mine.

What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.

0 likes 4mo
TI
t.ibarraTL230 Mar 2026 · edited#77
c.ostergaard, post #12: SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Post #75 and I disagree about the size of the effect, not about the direction.

Mechanistic reasoning about interactions has a poor predictive record. It is a good way to generate a question and a bad way to answer one.

17 likes in reply to #12 4mo
TN
t.nardoneTL3Regular31 Mar 2026#78
r.bakken, post #71: Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches. Correct me on the arithmetic if it is wrong; I would rather know. Go to post

Adding thanks rather than a view. I do not have a view worth the space.

7 likes in reply to #71 4mo
TB
t.batistaTL22 Apr 2026#79

I had written a reply contradicting post #75 and deleted it. Here is what survived.

Something worth flagging about Common supplements: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a coincidence.

3 likes 4mo
I
IsaksenTL3Regular3 Apr 2026#80
hana.sato, post #13: No notes. Posting so the count is not one. Go to post

Confirming post #79 from a second method, which matters more than confirming it from a second person.

Timing separation is the standard mitigation where absorption rate is the concern, and the interval that matters depends on the other drug rather than on this one.

0 likes in reply to #13 4mo
JP
j.palaciosTL25 Apr 2026#81

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

The general answer and the answer for your case may diverge here.

9 likes 4mo
VT
vial_tableTL2Member7 Apr 2026#82

Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the conservative reading is the obvious one.

I have no interest in any supplier named above.

21 likes 4mo
DV
d.vestergaardTL28 Apr 2026 · edited#83
vial_table, post #82: Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the conservative reading is the obvious one. I have no interest in any supplier named above. Go to post

Taking post #80 at face value and following it one step further.

Trying to state the Common supplements position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.

0 likes in reply to #82 4mo
F
FairweatherTL2Member10 Apr 2026#84

Distinguishing three things in the Common supplements discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets attached to both.

0 likes 4mo
BF
b.friskTL212 Apr 2026#85

That is clearer than the version I had in my head. Thank you.

14 likes 4mo
TK
t.kulkarniTL3Regular13 Apr 2026#86
n.rowntree, post #74: This follows post #71 rather than contradicting it. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this. Go to post

Answering the question post #82 raises rather than the one it answers.

Mechanistic reasoning about interactions has a poor predictive record. It is a good way to generate a question and a bad way to answer one.

I would treat the number as indicative rather than as a measurement.

28 likes in reply to #74 3mo
GO
g.oyelaranTL215 Apr 2026#87

Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is not supported.

The rule of thumb is fine; the edge cases are where it earns its keep.

0 likes 3mo
IL
integrator_logTL3Regular16 Apr 2026#88

What I would tell a new member reading about Common supplements for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.

2 likes 3mo
ND
n.duarteTL218 Apr 2026#89

Adding the measurement that post #88 says would settle it.

A note on scope: what I am saying about Common supplements applies to the case in the first post and I would not extend it further without checking.

2 likes 3mo
V
VPoulsenTL3Regular20 Apr 2026#90

Post #86 describes the usual case. This is about the unusual one.

Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.

10 likes 3mo